Soluble Fas Antigen and Soluble Fas Ligand in Intrauterine Growth Restriction

Publisher： Karger

E-ISSN： 1661-7819|97|1|31-35

ISSN： 1661-7800

Source： Neonatology, Vol.97, Iss.1, 2009-07, pp. : 31-35

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Maternal Smoking, Intrauterine Growth Restriction, and Placental Apoptosis

By Isaksen Christina Vogt  

Pediatric and Developmental Pathology, Vol. 7, Iss. 5, 2004-11 ,pp. : 433-442

Springer Publishing Company

Access to resources Recommend Favorite

Brain-Sparing in Intrauterine Growth Restriction: Considerations for the Neonatologist

By  

Neonatology, Vol. 108, Iss. 4, 2015-0 ,pp. : 269-276

Karger

Access to resources Recommend Favorite

Intrauterine Intervention for the Treatment of Fetal Growth Restriction

By  

Current Pediatric Reviews, Vol. 12, Iss. 3, 2016-09 ,pp. : 168-178

Bentham Science Publishers

Access to resources Recommend Favorite

CANCER CELL AND FAS LIGAND (CD95 LIGAND): IMMUNE ESCAPE OR SELF-ATTACK

By Uckan Duygu  

Pediatric Pathology & Molecular Medicine, Vol. 19, Iss. 4, 2000-07 ,pp. : 223-234

Informa Healthcare

Access to resources Recommend Favorite

Fetales Alkoholsyndrom (FAS)

By Feldmann R.   Löser† H.   Weglage J.  

Monatsschrift Kinderheilkunde, Vol. 155, Iss. 9, 2007-09 ,pp. : 853-865

Springer Publishing Company

Access to resources Recommend Favorite